COVID-19: Moderna and Novavax vaccines to be added to trial investigating the effect of mixing vaccines

The Com-Cov study launched in Feb 2021 with participants receiving alternating doses of the Oxford AstraZeneca and Pfizer vaccines. An additional 1050 volunteers will now be recruited onto the trial as 6 new arms are added. Mixing vaccines is not currently recommended in the UK.

British Medical Journal